0001209191-22-003715.txt : 20220119 0001209191-22-003715.hdr.sgml : 20220119 20220119162032 ACCESSION NUMBER: 0001209191-22-003715 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220114 FILED AS OF DATE: 20220119 DATE AS OF CHANGE: 20220119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUNN JOHN MICHAEL CENTRAL INDEX KEY: 0001238648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 22539025 MAIL ADDRESS: STREET 1: C/O VITAL THERAPIES, INC. STREET 2: 15010 AVENUE OF SCIENCE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-14 0 0001069308 Acer Therapeutics Inc. ACER 0001238648 DUNN JOHN MICHAEL C/O ACER THERAPEUTICS INC. 300 WASHINGTON STREET, STE. 351 NEWTON MA 02458 1 0 0 0 Stock Option (right to buy) 2.21 2022-01-14 4 A 0 18500 0.00 A 2032-01-14 Common Stock 18500 18500 D The option vests and becomes exercisable in full on January 14, 2023. /s/ Harry S. Palmin, Attorney-in-Fact 2022-01-19